disorder in main residue; R factor = 0.052; wR factor = 0.138; data-to-parameter ratio = 14.6. The title compound, C13H9BrF3N5O, crystallizes with two independent molecules in the asymmetric unit. The pyrimidine rings of the molecules are planar [maximum deviations 0.053 (3) and 0.012 (3) Å], while the triazine rings adopt flattened half-boat conformations with the p-bromophenyl rings in the flagpole positions. The crystal packing is stabilized by a three-dimensional network of intermolecular N—H N, N—H O and N—H F hydrogen bonds. Related literature For the crystal structure of 7,7-dimethyl-2-phenyl-6,7-dihydro
The asymmetric unit of the title compound, C19H16FN3O, contains two crystallographically independent...
The title molecule, C7H6BrN3, crystallizes with two molecules, A and B, in the asymmetric unit, with...
The title compound, C8H8Br4N2, crystallizes in the enantiomorphic-defining space group P41212 and ha...
disorder in main residue; R factor = 0.053; wR factor = 0.163; data-to-parameter ratio = 15.1. The t...
In the title compound, C14H8Br2F3NO, the molecule is disordered across an approximate non-crystallo...
The title compound, C26H23F3N4O, crystallizes with two symmetry-independent molecules in the asymmet...
The title compound, C13H9BrF3N5O, crystallizes with two independent molecules in the asymmetric unit...
In the title compound, C15H12ClF3N4O2, the dihydropyrimidine ring exhibits an envelope conformation....
The title compound, C15H12F2N2O2, crystallizes with two molecules (A and B) in the asymmetric unit. ...
The title compound, C20H19N5O2, exhibits whole-molecule disorder the refined ratios of the two compo...
The title compound, C15H12F2N2O2, crystallizes with two molecules (A and B) in the asymmetric unit. ...
R factor = 0.034; wR factor = 0.076; data-to-parameter ratio = 11.8. In the title compound, C13H10Br...
In the title compound, C15H10Br2N2O, one Br atom is disordered over two non-chemically equivalent si...
In the title compound, C14H11BrF3N5O2, the pyrimidine ring adopts a flattened envelope conformation ...
The asymmetric unit of the title compound, C15H12Br2F3NO2, consists of two crystallographically inde...
The asymmetric unit of the title compound, C19H16FN3O, contains two crystallographically independent...
The title molecule, C7H6BrN3, crystallizes with two molecules, A and B, in the asymmetric unit, with...
The title compound, C8H8Br4N2, crystallizes in the enantiomorphic-defining space group P41212 and ha...
disorder in main residue; R factor = 0.053; wR factor = 0.163; data-to-parameter ratio = 15.1. The t...
In the title compound, C14H8Br2F3NO, the molecule is disordered across an approximate non-crystallo...
The title compound, C26H23F3N4O, crystallizes with two symmetry-independent molecules in the asymmet...
The title compound, C13H9BrF3N5O, crystallizes with two independent molecules in the asymmetric unit...
In the title compound, C15H12ClF3N4O2, the dihydropyrimidine ring exhibits an envelope conformation....
The title compound, C15H12F2N2O2, crystallizes with two molecules (A and B) in the asymmetric unit. ...
The title compound, C20H19N5O2, exhibits whole-molecule disorder the refined ratios of the two compo...
The title compound, C15H12F2N2O2, crystallizes with two molecules (A and B) in the asymmetric unit. ...
R factor = 0.034; wR factor = 0.076; data-to-parameter ratio = 11.8. In the title compound, C13H10Br...
In the title compound, C15H10Br2N2O, one Br atom is disordered over two non-chemically equivalent si...
In the title compound, C14H11BrF3N5O2, the pyrimidine ring adopts a flattened envelope conformation ...
The asymmetric unit of the title compound, C15H12Br2F3NO2, consists of two crystallographically inde...
The asymmetric unit of the title compound, C19H16FN3O, contains two crystallographically independent...
The title molecule, C7H6BrN3, crystallizes with two molecules, A and B, in the asymmetric unit, with...
The title compound, C8H8Br4N2, crystallizes in the enantiomorphic-defining space group P41212 and ha...